From Lab To Patient
September 17, 2013
An innovative project at the University of Missouri is funding projects that involve both engineers and doctors. The Coulter Translational Partnership (CTP) Program has funded eight projects over the past two years, including topics such as tissue grafting, cancer treatment and neurodevelopmental disorders. MU’s Department of Bioengineering, home to this project, is a joint effort of CAFNR and the College of Engineering.
Story by: Amy Zuroweste CAFNRnews
A project housed in the Department of Bioengineering at the University of Missouri hopes to speed up the process by which biomedical engineering solutions can be brought to market to help patients.
The Coulter Translational Partnership (CTP) Program funds collaborative projects between engineers and clinicians. MU’s program is one of only 15 across the nation – and the only one in Missouri. Bioengineering – a joint department in the College of Agriculture, Food and Natural Resources and the College of Engineering – started administering the partnership at Mizzou in 2012.
“The program increases the capacity and pace of biomedical innovation,” said Rebecca Rone, MU program director. “The projects selected ultimately benefit patients by addressing unmet clinical needs.”
Funding awarded under the CTP program is focused on bringing biomedical engineering solutions to the point at which they become attractive for follow-on funding. This is accomplished through evaluating the project in aspects such as intellectual property and market opportunity, identifying and engaging early with potential partners with financing and product development capabilities, and then funding specific experiments in a disciplined, managed process. See more…